State-of-Art of Cellular Therapy for Acute Leukemia
With recent clinical breakthroughs, immunotherapy has become the fourth pillar of cancer treatment. Particularly, immune cell-based therapies have been envisioned as a promising treatment option with curative potential for leukemia patients. Hence, an increasing number of preclinical and clinical st...
Main Authors: | Jong-Bok Lee, Daniel Vasic, Hyeonjeong Kang, Karen Kai-Lin Fang, Li Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/9/4590 |
Similar Items
-
Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy
by: Branson Chen, et al.
Published: (2018-04-01) -
New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
by: Mehmet Gunduz, et al.
Published: (2021-09-01) -
Natural killer cell-based immunotherapy for acute myeloid leukemia
by: Jing Xu, et al.
Published: (2020-12-01) -
Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia
by: Mark Gurney, et al.
Published: (2021-03-01) -
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
by: Marco Cerrano, et al.
Published: (2020-05-01)